High Throughput Approaches to Unravel the Mechanism of Action of a New Vanadium-Based Compound against Trypanosoma cruzi
Treatment for Chagas disease, a parasitosis caused by Trypanosoma cruzi, has always been based on two drugs, nifurtimox and benznidazole, despite the toxic side effects described after prolonged prescription. In this work, we study a new prospective antitrypanosomal drug based on vanadium, here name...
Saved in:
Main Authors: | M. Florencia Mosquillo, Pablo Smircich, Analía Lima, Sergio A. Gehrke, Gonzalo Scalese, Ignacio Machado, Dinorah Gambino, Beatriz Garat, Leticia Pérez-Díaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2020/1634270 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Evasion Strategies of Trypanosoma cruzi
by: Ana Flávia Nardy, et al.
Published: (2015-01-01) -
Alternative transmission modes for Trypanosoma cruzi
by: Christopher M. Kribs-Zaleta
Published: (2010-05-01) -
Trypanosoma cruzi Infection and Host Lipid Metabolism
by: Qianqian Miao, et al.
Published: (2014-01-01) -
Lysophosphatidylcholine: A Novel Modulator of Trypanosoma cruzi Transmission
by: Mário A. C. Silva-Neto, et al.
Published: (2012-01-01) -
<i>Trypanosoma cruzi</i>: Genomic Diversity and Structure
by: Alfonso Herreros-Cabello, et al.
Published: (2025-01-01)